ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2207

Menopause Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis

Catherine Sims1, Yujung Choi2, Abigail Shapiro3, Jennifer Gierisch1, Elizabeth Strawbridge2, Teresa Howard2, Ankoor Shah1 and Karen Goldstein1, 1VA Durham Healthcare System, Duke University, Durham, 2VA Durham Healthcare System, Durham, 3VA Durham Healthcare System, Cleveland

Meeting: ACR Convergence 2025

Keywords: Hormone Replacement Therapy, rheumatoid arthritis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2195–2226) Reproductive Issues in Rheumatic Disorders Posters

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: There is a significant gap in understanding the reproductive health experiences of women Veterans with rheumatoid arthritis (RA). This study explores their experiences with menopause within the VA healthcare system, including perceptions of rheumatologists’ roles in symptom management and care coordination between rheumatology and other providers.

Methods: Semi-structured interviews with 9 VA healthcare providers (5 rheumatologists, 4 primary care providers) and 7 Veterans with RA explored reproductive healthcare experiences and needs within the VA. All Veterans self-identified as Black and had been evaluated by a rheumatologist for RA. Veterans were identified via the Corporate Data Warehouse. Of the 128 Veterans contacted, 31 consented. Interview guides were developed using the Chronic Care and Cumulative Complexity Models to explore contraception, pregnancy, and menopause. Interviews were audio-recorded and transcribed using Microsoft Teams. Data were analyzed using Hamilton’s rapid qualitative method. Two analysts summarized individual and cross-participant levels, with input from a third analyst. Overall themes were identified through structured matrix analysis.

Results: We interviewed 7 Veterans about experiences with menopause symptoms and therapies, median age 61 years (Table 1). Veterans reported joint pain and swelling that disrupted daily activities related to their RA. Veterans described difficulty with differentiating menopause symptoms from RA and relied on rheumatologists for guidance. They valued discussions with their rheumatologists about menopause and hormone therapy (HT) and its impacts on RA. Veterans drew on clinical advice and personal considerations when making decisions about menopause therapy. Some utilized supportive care, supplements, or HT to address menopausal symptoms. Some Veterans decided against HT due to medication burden or history of thrombosis. VA rheumatologists and PCPs expressed lower confidence in managing menopause compared to other reproductive health concerns and reported a generalized approach, as opposed to a disease-tailored approach, to menopause in Veterans with RA. Both Veterans and providers noted a lack of patient and provider resources for women with autoimmune disease undergoing menopause. Veterans believed that better access to reliable, personalized resources would have enhanced their menopause experience (Figure 1).

Conclusion: These findings highlight the challenges faced by Veterans with RA in managing menopause symptoms, particularly in distinguishing between RA-related and menopause-related symptoms. Veterans valued the involvement of their rheumatologists and want more guidance on menopause and HT, especially in relation to its impact on RA. Both Veterans and VA providers identified a gap in tailored resources and personalized approaches for women with RA undergoing menopause.

Supporting image 1Table 1. Patient Characteristics

Supporting image 2Figure 1. Emergent Themes in Menopause Experiences of Veterans with Rheumatoid Arthritis


Disclosures: C. Sims: None; Y. Choi: None; A. Shapiro: Amgen, 12, Patient Advisory Board member- unrelated to this work; J. Gierisch: None; E. Strawbridge: None; T. Howard: None; A. Shah: None; K. Goldstein: None.

To cite this abstract in AMA style:

Sims C, Choi Y, Shapiro A, Gierisch J, Strawbridge E, Howard T, Shah A, Goldstein K. Menopause Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/menopause-experiences-of-veterans-from-minoritized-populations-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/menopause-experiences-of-veterans-from-minoritized-populations-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology